
The new indication for rosuvastatin is unlikely to have any significant impact on clinical practices because of questions about its clinical utility.

Published: August 11th 2010 | Updated:

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
